当前位置:科学网首页 > 小柯机器人 >详情
研究揭示脑膜瘤异质性和演化的空间基因组、生化和细胞机制
作者:小柯机器人 发布时间:2024/5/21 16:32:56

美国加州大学旧金山分校David R. Raleigh课题组揭示脑膜瘤异质性和演化的空间基因组、生化和细胞机制。该研究于2024年5月17日在线发表于国际一流学术期刊《自然—遗传学》。

研究人员利用空间方法来确定将瘤内异质性与高级别脑膜瘤的分子、时间和空间演变联系起来的基因组、生化和细胞机制。研究表明,肿瘤内不同的基因和蛋白质表达程序将高级别脑膜瘤区分开来,而目前的分类系统则将这些肿瘤归为一类。对配对的原发性和复发性脑膜瘤的分析表明,亚克隆拷贝数变异的空间扩展与耐药性有关。
 
使用单细胞RNA测序的细胞类型,对脑膜瘤空间转录组进行多重序列免疫荧光和解旋显示,免疫浸润减少、MAPK信号传导减少、PI3K-AKT信号传导增加以及细胞增殖增加与脑膜瘤复发有关。为了将这些发现转化为临床前模型,研究人员使用CRISPR干扰和系谱追踪方法,确定了针对脑膜瘤细胞共培养中瘤内异质性的组合疗法。

据悉,肿瘤内异质性是癌症演化和耐药性的基础,但人们对驱动肿瘤内异质性的靶向机制知之甚少。脑膜瘤是最常见的原发性颅内肿瘤,对所有药物疗法都有抗药性,高级别脑膜瘤具有显著的瘤内异质性。

附:英文原文

Title: Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution

Author: Lucas, Calixto-Hope G., Mirchia, Kanish, Seo, Kyounghee, Najem, Hinda, Chen, William C., Zakimi, Naomi, Foster, Kyla, Eaton, Charlotte D., Cady, Martha A., Choudhury, Abrar, Liu, S. John, Phillips, Joanna J., Magill, Stephen T., Horbinski, Craig M., Solomon, David A., Perry, Arie, Vasudevan, Harish N., Heimberger, Amy B., Raleigh, David R.

Issue&Volume: 2024-05-17

Abstract: Intratumor heterogeneity underlies cancer evolution and treatment resistance, but targetable mechanisms driving intratumor heterogeneity are poorly understood. Meningiomas are the most common primary intracranial tumors and are resistant to all medical therapies, and high-grade meningiomas have significant intratumor heterogeneity. Here we use spatial approaches to identify genomic, biochemical and cellular mechanisms linking intratumor heterogeneity to the molecular, temporal and spatial evolution of high-grade meningiomas. We show that divergent intratumor gene and protein expression programs distinguish high-grade meningiomas that are otherwise grouped together by current classification systems. Analyses of matched pairs of primary and recurrent meningiomas reveal spatial expansion of subclonal copy number variants associated with treatment resistance. Multiplexed sequential immunofluorescence and deconvolution of meningioma spatial transcriptomes using cell types from single-cell RNA sequencing show decreased immune infiltration, decreased MAPK signaling, increased PI3K–AKT signaling and increased cell proliferation, which are associated with meningioma recurrence. To translate these findings to preclinical models, we use CRISPR interference and lineage tracing approaches to identify combination therapies that target intratumor heterogeneity in meningioma cell co-cultures.

DOI: 10.1038/s41588-024-01747-1

Source: https://www.nature.com/articles/s41588-024-01747-1

期刊信息

Nature Genetics:《自然—遗传学》,创刊于1992年。隶属于施普林格·自然出版集团,最新IF:41.307
官方网址:https://www.nature.com/ng/
投稿链接:https://mts-ng.nature.com/cgi-bin/main.plex